-
Reply: Peripherin is a biomarker of axonal damage in Guillain-Barré syndrome: a pathophysiological annotation
Keddie, S., Smyth, D., Keh, R. Y. S., Wieske, L., Michael, M., Eftimov, F., Bellanti, R., Rinaldi, S., Petzold, A. & Lunn, M. P., 1 Jan 2024, In: Brain. 147, 1, p. E3-E4Research output: Contribution to journal › Letter › Academic › peer-review
-
Peripherin is a biomarker of axonal damage in peripheral nervous system disease
Keddie, S., Smyth, D., Keh, R. Y. S., Chou, M. K. L., Grant, D., Surana, S., Heslegrave, A., Zetterberg, H., Wieske, L., Michael, M., Eftimov, F., Bellanti, R., Rinaldi, S., Hart, M. S., Petzold, A. & Lunn, M. P., 1 Nov 2023, In: Brain. 146, 11, p. 4562-4573Research output: Contribution to journal › Article › Academic › peer-review
-
Serum B-cell activating factor is not a potential biomarker for disease activity in chronic inflammatory demyelinating polyneuropathy
Michael, M. R., Wieske, L., Koel-Simmelink, M. J., van Schaik, I. N., Teunissen, C. E. & Eftimov, F., 15 Sept 2023, In: Journal of Neuroimmunology. 382, 578169.Research output: Contribution to journal › Article › Academic › peer-review
- All publications
